CSBG: Carotid subclavian bypass graft; PTA: Percutaneous transluminal angioplasty. The treatment of subclavian artery occlusive disease has evolved from surgery to percutaneous-based treatment ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the ...

Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.

A 75-year-old female patient was admitted to the hospital because of persistent left-sided thoracic pain with projection to the left arm. [18] After exclusion of acute myocardial infarction or ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment ...